- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Total 3245 results
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaBelgium, Spain, Austria, Germany, Italy, France, Netherlands, Sweden, Japan, United States, Greece, United Kingdom, Bulgaria, Hungary, Argentina, Poland, Colombia, Ireland, Denmark
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Diavax BiosciencesActive, not recruitingHodgkin Lymphoma | Myelofibrosis | Lymphoblastic Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Lymphadenopathy | Myeloproliferative Neoplasm | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Myeloid Leukemia in Remission | Accelerated Phase... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Accelerated Phase Chronic Myelogenous Leukemia | Childhood Chronic Myelogenous Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic... and other conditionsUnited States
-
ShireCompleted
-
M.D. Anderson Cancer CenterCompletedMyelogenous Leukemia, ChronicUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompleted
-
Medical Research CouncilUnknownLeukemiaUnited Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
German CML Study GroupUnknown
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
NovartisNational Cancer Institute (NCI)Completed
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
Children's Oncology GroupPfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...Active, not recruitingAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CMLUnited States
-
Medical College of WisconsinH. Jean Khoury Cure CML ConsortiumRecruitingChronic Phase Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia (CML) | Blast Phase Chronic Myelogenous Leukemia (CML) | Chronic Phase Phase Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)United States
-
Mayo ClinicWithdrawnB-cell Adult Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsRecruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myelogenous Leukemia - Chronic PhaseChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
NovartisCompleted
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsTerminatedMyelogenous LeukemiaUnited States, Germany, Belgium, Italy, Spain, Korea, Republic of, Brazil, Japan, Australia, Czech Republic
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterCompletedMyelodysplastic Syndrome (MDS) | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic Leukemia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Blasts Under 5 Percent of Bone Marrow...United States
-
Centre Hospitalier Universitaire de NiceUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Asan Medical CenterCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKorea, Republic of, Canada
-
Hackensack Meridian HealthTerminatedMyeloproliferative Disorders | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloid MalignanciesUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
National Taiwan University HospitalRecruitingChronic Myeloid Leukemia, BCR/ABL-PositiveTaiwan
-
Bristol-Myers SquibbCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChina
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaTurkey
-
Loyola UniversityNational Cancer Institute (NCI)Completed
-
PETHEMA FoundationCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Myelomonocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedHematologic Diseases | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Agnogenic Myeloid MetaplasiaUnited States
-
Versailles HospitalRecruitingLeukemia, Myeloid, Chronic-PhaseFrance
-
Novartis PharmaceuticalsRecruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myelogenous LeukemiaDenmark, Spain, France, Germany, Lebanon, Italy, Argentina, Czechia, Portugal, United Kingdom, Brazil, Mexico, Russian Federation, Taiwan, Austria, Canada, Korea, Republic of, Turkey, United States, Singapore, Japan, Bulgaria, Poland, Romani... and more
-
Hospital Universitario Dr. Jose E. GonzalezFernando De la Garza SalazarRecruitingChronic Myeloid Leukemia, Chronic PhaseMexico
-
Novartis PharmaceuticalsTerminatedChronic Myelogenous Leukemia - Chronic PhaseUnited States